Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuning Wang

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Nanobiotechnology|February 9, 2023
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signalingXiao Liu, Qingdong Guo, Guangxun Gao, et al.
Biomed Research International|June 1, 2018
A Single Codon Optimization Enhances Recombinant Human TNF-<i>α</i> Vaccine Expression in <i>Escherichia coli</i>Chu Chu, Wangqian Zhang, Jialin Li, et al.
Cell Death & Disease|March 18, 2018
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancerYuan Gao, Xiaoju Li, Zhen Shu, et al.
Frontiers in Oncology|July 11, 2022
Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular CarcinomaXiaoju Li, Qianqian Yu, Runze Zhao, et al.
Scientific Reports|January 30, 2016
A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritisNan Mu, Jintao Gu, Tonglie Huang, et al.
Cell Communication and Signaling : CCS|October 15, 2025
GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinomaGege Shi, Wangqian Zhang, Fei Xie, et al.
Journal of Nanobiotechnology|January 4, 2025
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancerChenlin Liu, Dong Fan, Jiahui Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma CarcinomaLei He, Zhaozhao Li, Danjie Su, et al.
Biochemical Pharmacology|January 20, 2026
Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunityMaorong Zhu, Yuxin Wu, Kuo Zhang, et al.
Journal of Nanobiotechnology|February 20, 2025
Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticlesCheng Zou, Xiao Liu, Weizhong Wang, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Nanobiotechnology|February 9, 2023
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signalingXiao Liu, Qingdong Guo, Guangxun Gao, et al.
Biomed Research International|June 1, 2018
A Single Codon Optimization Enhances Recombinant Human TNF-<i>α</i> Vaccine Expression in <i>Escherichia coli</i>Chu Chu, Wangqian Zhang, Jialin Li, et al.
Cell Death & Disease|March 18, 2018
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancerYuan Gao, Xiaoju Li, Zhen Shu, et al.
Frontiers in Oncology|July 11, 2022
Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular CarcinomaXiaoju Li, Qianqian Yu, Runze Zhao, et al.
Scientific Reports|January 30, 2016
A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritisNan Mu, Jintao Gu, Tonglie Huang, et al.
Cell Communication and Signaling : CCS|October 15, 2025
GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinomaGege Shi, Wangqian Zhang, Fei Xie, et al.
Journal of Nanobiotechnology|January 4, 2025
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancerChenlin Liu, Dong Fan, Jiahui Sun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma CarcinomaLei He, Zhaozhao Li, Danjie Su, et al.
Biochemical Pharmacology|January 20, 2026
Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunityMaorong Zhu, Yuxin Wu, Kuo Zhang, et al.
Journal of Nanobiotechnology|February 20, 2025
Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticlesCheng Zou, Xiao Liu, Weizhong Wang, et al.
Pageof 10